Interventions for the management of obesity in people with bipolar disorder.

The Cochrane Database of Systematic Reviews
Agnes TullyFionnuala Jordan

Abstract

Bipolar disorder is one of the most common serious mental illnesses, affecting approximately 60 million people worldwide. Characterised by extreme alterations in mood, cognition, and behaviour, bipolar disorder can have a significant negative impact on the functioning and quality of life of the affected individual. Compared with the general population, the prevalence of comorbid obesity is significantly higher in bipolar disorder. Approximately 68% of treatment seeking bipolar patients are overweight or obese. Clinicians are aware that obesity has the potential to contribute to other physical health conditions in people with bipolar disorder, including diabetes, hypertension, metabolic syndrome, cardiovascular disease, and coronary heart disease. Cardiovascular disease is the leading cause of premature death in bipolar disorder, happening a decade or more earlier than in the general population. Contributing factors include illness-related factors (mood-related factors, i.e. mania or depression), treatment-related factors (weight implications and other side effects of medications), and lifestyle factors (physical inactivity, poor diet, smoking, substance abuse). Approaches to the management of obesity in individuals with bipolar...Continue Reading

References

Nov 1, 1978·The British Journal of Psychiatry : the Journal of Mental Science·R C YoungD A Meyer
May 1, 1995·The British Journal of Psychiatry : the Journal of Mental Science·S H JonesG Dunn
Aug 12, 1999·Acta Psychiatrica Scandinavica·T Baptista
Mar 24, 2000·Pharmacotherapy·A M HeckK A Calis
Apr 26, 2001·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·R S McIntyreS H Kennedy
Jul 18, 2002·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·K R Fontaine, I Barofsky
Dec 31, 2002·The American Journal of Psychiatry·Andrea FagioliniEllen Frank
Jun 17, 2003·PharmacoEconomics·Leah KleinmanDennis Revicki
Sep 6, 2003·BMJ : British Medical Journal·Julian P T HigginsDouglas G Altman
Feb 1, 1960·Journal of Neurology, Neurosurgery, and Psychiatry·M HAMILTON
May 28, 2004·The Journal of Clinical Psychiatry·Susan L McElroyCharles B Nemeroff
Dec 2, 2004·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Walter DeberdtAlan Breier
Apr 23, 2005·The Cochrane Database of Systematic Reviews·K ShawJ Kenardy
Jun 10, 2005·The Australian and New Zealand Journal of Psychiatry·Sherryn EvansSally Higgins
Sep 21, 2005·The New England Journal of Medicine·Jeffrey A LiebermanUNKNOWN Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators
Jul 5, 2006·Archives of General Psychiatry·Gregory E SimonRonald C Kessler
Jan 9, 2007·Lancet·Raj S Padwal, Sumit R Majumdar
Apr 11, 2007·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·David C W LauUNKNOWN Obesity Canada Clinical Practice Guidelines Expert Panel
Jun 15, 2007·Human Psychopharmacology·Jeanette M Jerrell, Roger S McIntyre
Apr 26, 2008·BMJ : British Medical Journal·Gordon H GuyattUNKNOWN GRADE Working Group
Jan 15, 2009·Journal of Clinical Psychopharmacology·Jochem G GregoorEibert R Heerdink
Jan 31, 2009·Acta Psychiatrica Scandinavica·S M StahlJ M Meyer
Jul 11, 2009·The Journal of Clinical Psychiatry·Susan L McElroy
Jun 15, 2010·Journal of Affective Disorders·Roger S McIntyreValerie H Taylor
Aug 3, 2010·Psychiatric Services : a Journal of the American Psychiatric Association·Leopoldo J CabassaRoberto Lewis-Fernández
Nov 3, 2010·Bipolar Disorders·Erin E MichalakUNKNOWN Collaborative RESearch Team to Study Psychosocial Issues in Bipolar Disorder (CREST.BD)
Jan 18, 2011·Community Mental Health Journal·Michael UssherRobert West
Jan 29, 2011·Primary Care Companion to the Journal of Clinical Psychiatry·Kornelia GillhoffWaldemar Greil
Feb 18, 2011·Mens Sana Monographs·Amresh Shrivastava, Megan E Johnston
Mar 8, 2011·World Psychiatry : Official Journal of the World Psychiatric Association (WPA)·Marc DE HertStefan Leucht
Mar 9, 2011·Archives of General Psychiatry·Kathleen R MerikangasZahari Zarkov
Sep 20, 2011·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Anders GustavssonUNKNOWN CDBE2010Study Group
Oct 21, 2011·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Kathryn M Hurren, Helen D Berlie
Mar 20, 2012·Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery·Julie MerrellLeslie Heinberg

❮ Previous
Next ❯

Citations

Jan 26, 2021·Expert Review of Neurotherapeutics·Lais B MartinsAntônio L Teixeira

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic-Induced Weight Gain

Antipsychotic-induced weight gain (aiwg) is a common adverse effect of this treatment, particularly with second-generation antipsychotics, and it is a major health problem around the world. Here are the latest discoveries pertaining to AIWG.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Cardiovascular Disorder in Diabetes

Diabetes is associated with an increased risk of cardiovascular disorders and heart failure. Discover the latest research here.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Bipolar Disorder

Bipolar disorder is characterized by manic and/or depressive episodes and associated with uncommon shifts in mood, activity levels, and energy. Discover the latest research this illness here.